Correlation Between CompuGroup Medical and BioNTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CompuGroup Medical and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CompuGroup Medical and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CompuGroup Medical AG and BioNTech SE, you can compare the effects of market volatilities on CompuGroup Medical and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CompuGroup Medical with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of CompuGroup Medical and BioNTech.

Diversification Opportunities for CompuGroup Medical and BioNTech

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between CompuGroup and BioNTech is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding CompuGroup Medical AG and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and CompuGroup Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CompuGroup Medical AG are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of CompuGroup Medical i.e., CompuGroup Medical and BioNTech go up and down completely randomly.

Pair Corralation between CompuGroup Medical and BioNTech

Assuming the 90 days trading horizon CompuGroup Medical AG is expected to under-perform the BioNTech. But the stock apears to be less risky and, when comparing its historical volatility, CompuGroup Medical AG is 1.05 times less risky than BioNTech. The stock trades about -0.05 of its potential returns per unit of risk. The BioNTech SE is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  17,978  in BioNTech SE on September 13, 2024 and sell it today you would lose (6,063) from holding BioNTech SE or give up 33.72% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.42%
ValuesDaily Returns

CompuGroup Medical AG  vs.  BioNTech SE

 Performance 
       Timeline  
CompuGroup Medical 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CompuGroup Medical AG are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, CompuGroup Medical unveiled solid returns over the last few months and may actually be approaching a breakup point.
BioNTech SE 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent essential indicators, BioNTech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

CompuGroup Medical and BioNTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CompuGroup Medical and BioNTech

The main advantage of trading using opposite CompuGroup Medical and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CompuGroup Medical position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.
The idea behind CompuGroup Medical AG and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity